209 related articles for article (PubMed ID: 34290170)
1. IL-13 gene polymorphisms (-1112 C/T and -1512 A/C) in patients with chronic and aggressive periodontitis: Effects on GCF and outcome of periodontal therapy.
Gorgun EP; Toker H; Tas A; Alpan AL; Sari I; Silig Y
Niger J Clin Pract; 2021 Jul; 24(7):965-972. PubMed ID: 34290170
[TBL] [Abstract][Full Text] [Related]
2. Short term effects of non-surgical periodontal treatment on gingival crevicular fluid levels of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 2 (PAI-2) in patients with chronic and aggressive periodontitis.
Tüter G; Ozdemir B; Kurtiş B; Serdar M; Yücel AA; Ayhan E
Arch Oral Biol; 2013 Apr; 58(4):391-6. PubMed ID: 22980426
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of IL-1β, IL-1ra, and IL-10 levels and outcome of periodontal therapy in chronic periodontitis with familial Mediterranean fever.
Bostanci V; Toker H; Senel S; Poyraz O; Akpinar A; Görgün EP; Bakar O
Clin Oral Investig; 2017 Jan; 21(1):469-475. PubMed ID: 27068409
[TBL] [Abstract][Full Text] [Related]
4. Gingival crevicular fluid interleukin-36β (-1F8), interleukin-36γ (-1F9) and interleukin-33 (-1F11) levels in different periodontal disease.
Kurşunlu SF; Oztürk VÖ; Han B; Atmaca H; Emingil G
Arch Oral Biol; 2015 Jan; 60(1):77-83. PubMed ID: 25247780
[TBL] [Abstract][Full Text] [Related]
5. Association of interleukin-1 beta (+3954) gene polymorphism and gingival crevicular fluid levels in patients with aggressive and chronic periodontitis.
Yücel OO; Berker E; Mescil L; Eratalay K; Tepe E; Tezcan I
Genet Couns; 2013; 24(1):21-35. PubMed ID: 23610862
[TBL] [Abstract][Full Text] [Related]
6. The effects of IL-10 gene polymorphism on serum, and gingival crevicular fluid levels of IL-6 and IL-10 in chronic periodontitis.
Toker H; Gorgun EP; Korkmaz EM; Yüce HB; Poyraz O
J Appl Oral Sci; 2018; 26():e20170232. PubMed ID: 29489938
[TBL] [Abstract][Full Text] [Related]
7. IL-6 and IL-10 gene polymorphisms in patients with aggressive periodontitis: effects on GCF, serum and clinic parameters.
Pirim Gorgun E; Toker H; Korkmaz EM; Poyraz O
Braz Oral Res; 2017 Jan; 31():e12. PubMed ID: 28099578
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of gingival crevicular fluid cyclophilin a and extracellular matrix metalloproteinase inducer levels in different periodontal diseases.
Eren G; Türkoğlu O; Atmaca H; Atilla G
Arch Oral Biol; 2016 Aug; 68():162-6. PubMed ID: 27176139
[TBL] [Abstract][Full Text] [Related]
9. Correlations between Interleukin-33 and -1α Levels in Gingival Crevicular Fluid and Plasma in Patients with Chronic or Aggressive Periodontitis and Disease-free Subjects.
Pai B S; Pradeep AR
Bull Tokyo Dent Coll; 2019 Dec; 60(4):279-289. PubMed ID: 31761881
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of gingival crevicular fluid levels of tissue plasminogen activator, plasminogen activator inhibitor 2, matrix metalloproteinase-3 and interleukin 1-β in patients with different periodontal diseases.
Toyman U; Tüter G; Kurtiş B; Kıvrak E; Bozkurt Ş; Yücel AA; Serdar M
J Periodontal Res; 2015 Feb; 50(1):44-51. PubMed ID: 24690077
[TBL] [Abstract][Full Text] [Related]
11. Soluble interleukin-1 receptor type II levels in gingival crevicular fluid in aggressive and chronic periodontitis.
Suzuki M; Ishihara Y; Kamiya Y; Koide M; Fuma D; Fujita S; Matsumura Y; Suga T; Kamei H; Noguchi T
J Periodontol; 2008 Mar; 79(3):495-500. PubMed ID: 18315432
[TBL] [Abstract][Full Text] [Related]
12. Gingival Crevicular Fluid and Salivary Periostin Levels in Non-Smoker Subjects With Chronic and Aggressive Periodontitis : Periostin Levels in Chronic and Aggressive Periodontitis.
Aral CA; Köseoğlu S; Sağlam M; Pekbağrıyanık T; Savran L
Inflammation; 2016 Jun; 39(3):986-93. PubMed ID: 26931107
[TBL] [Abstract][Full Text] [Related]
13. Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis.
Kurtiş B; Tüter G; Serdar M; Akdemir P; Uygur C; Firatli E; Bal B
J Periodontol; 2005 Nov; 76(11):1849-55. PubMed ID: 16274303
[TBL] [Abstract][Full Text] [Related]
14. Biomarker levels in gingival crevicular fluid of subjects with different periodontal conditions: A cross-sectional study.
Zhang Q; Chen B; Zhu D; Yan F
Arch Oral Biol; 2016 Dec; 72():92-98. PubMed ID: 27565354
[TBL] [Abstract][Full Text] [Related]
15. MMP-13 promoter polymorphisms in patients with chronic periodontitis: effects on GCF MMP-13 levels and outcome of periodontal therapy.
Pirhan D; Atilla G; Emingil G; Tervahartiala T; Sorsa T; Berdeli A
J Clin Periodontol; 2009 Jun; 36(6):474-81. PubMed ID: 19453573
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17 levels in gingival crevicular fluid of aggressive periodontitis and chronic periodontitis patients.
Wankhede AN; Dhadse PV
J Indian Soc Periodontol; 2022; 26(6):552-556. PubMed ID: 36582957
[TBL] [Abstract][Full Text] [Related]
17. Gingival crevicular fluid calprotectin, osteocalcin and cross-linked N-terminal telopeptid levels in health and different periodontal diseases.
Becerik S; Afacan B; Oztürk VÖ; Atmaca H; Emingil G
Dis Markers; 2011; 31(6):343-52. PubMed ID: 22182807
[TBL] [Abstract][Full Text] [Related]
18. The effects of non-surgical periodontal therapy on oxidant and anti-oxidant status in smokers with chronic periodontitis.
Akpinar A; Toker H; Ozdemir H; Bostanci V; Aydin H
Arch Oral Biol; 2013 Jun; 58(6):717-23. PubMed ID: 23261252
[TBL] [Abstract][Full Text] [Related]
19. Effect of non-surgical periodontal treatment on gingival crevicular fluid hypoxia inducible factor-1 alpha, vascular endothelial growth factor and tumor necrosis factor-alpha levels in generalized aggressive periodontitis patients.
Afacan B; Keleş Yücel ZP; Paşali Ç; Atmaca İlhan H; Köse T; Emingil G
J Periodontol; 2020 Nov; 91(11):1495-1502. PubMed ID: 32246842
[TBL] [Abstract][Full Text] [Related]
20. Effect of periodontal treatment on IL-1beta, IL-1ra, and IL-10 levels in gingival crevicular fluid in patients with aggressive periodontitis.
Toker H; Poyraz O; Eren K
J Clin Periodontol; 2008 Jun; 35(6):507-13. PubMed ID: 18371054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]